We are live on ! Find out more
State of Wisconsin Investment Board

State of Wisconsin Investment Board Portfolio holdings

AUM $43.7B
1-Year Est. Return 27.76%
This Fund
S&P 500
This Quarter Est. Return
-13.3%
1 Year Est. Return
+27.76%
3 Year Est. Return
+95.56%
5 Year Est. Return
+123.77%
10 Year Est. Return
+486.44%
AUM
$30.7B
AUM Growth
-$5.52B
Cap. Flow
-$219M
Cap. Flow %
-0.71%
Top 10 Hldgs %
16.4%
Holding
1,624
New
85
Increased
603
Reduced
480
Closed
83

Top Buys

Rank Stock Value
1
DOCU
DocuSign
DOCU
+$126M
2
LIN icon
Linde
LIN
+$121M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$108M
4
CI icon
Cigna
CI
+$58.9M
5
CUK
Carnival PLC
CUK
+$43M

Top Sells

Rank Stock Value
1
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
+$140M
2
ESRX
Express Scripts Holding Company
ESRX
+$103M
3
AET
Aetna Inc
AET
+$99.9M
4
DELL icon
Dell
DELL
+$88.2M
5
COL
Rockwell Collins
COL
+$58M

Sector Composition

Rank Sector Weight
1 Technology 17.28%
2 Financials 15.79%
3 Healthcare 13.93%
4 Consumer Discretionary 10.06%
5 Industrials 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DOVA
1501
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
$93K ﹤0.01%
12,300
– –
PFNX
1502
DELISTED
Pfenex Inc.
PFNX
$91K ﹤0.01%
+28,600
New +$122K
CUE icon
1503
Cue Biopharma
CUE
$128M
$87K ﹤0.01%
+617
New +$112K
KA
1504
DELISTED
Kineta, Inc. Common Stock
KA
$86K ﹤0.01%
+189
New +$128K
LCTX icon
1505
Lineage Cell Therapeutics
LCTX
$278M
$84K ﹤0.01%
92,400
+27,249
+42% +$41.7K
VRDN icon
1506
Viridian Therapeutics
VRDN
$2.59B
$83K ﹤0.01%
1,820
+1,153
+173% +$66.7K
ARDX icon
1507
Ardelyx
ARDX
$1.03B
$80K ﹤0.01%
44,900
+19,900
+80% +$58.6K
DRRX
1508
DELISTED
DURECT Corp
DRRX
$80K ﹤0.01%
16,500
+6,800
+70% +$59.3K
FENC icon
1509
Fennec Pharmaceuticals
FENC
$414M
$77K ﹤0.01%
+12,000
New +$83.9K
TBIO
1510
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$76K ﹤0.01%
+10,100
New +$74K
CWBR
1511
DELISTED
CohBar, Inc. Common Stock
CWBR
$75K ﹤0.01%
+807
New +$89.7K
ALNA
1512
DELISTED
Allena Pharmaceuticals
ALNA
$65K ﹤0.01%
+12,000
New +$103K
SNDX icon
1513
Syndax Pharmaceuticals
SNDX
$1.77B
$64K ﹤0.01%
+14,400
New +$78.9K
TTPH
1514
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$62K ﹤0.01%
2,735
+1,335
+95% +$52.2K
KALA icon
1515
KALA BIO
KALA
$17.1M
$59K ﹤0.01%
+5
New +$86.7K
TLGT
1516
DELISTED
Teligent, Inc
TLGT
$58K ﹤0.01%
4,230
+1,130
+36% +$29.5K
ACGN
1517
DELISTED
Aceragen Inc
ACGN
$55K ﹤0.01%
+1,170
New +$134K
JNCE
1518
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$55K ﹤0.01%
+16,300
New +$76.1K
MRSN
1519
DELISTED
Mersana Therapeutics
MRSN
$53K ﹤0.01%
+520
New +$82.3K
CRVS icon
1520
Corvus Pharmaceuticals
CRVS
$1.27B
$52K ﹤0.01%
+14,300
New +$97.5K
ZOM
1521
DELISTED
Zomedica Corp.
ZOM
$52K ﹤0.01%
+42,600
New +$67.5K
MBIO icon
1522
Mustang Bio
MBIO
$4.61M
$49K ﹤0.01%
+22
New +$66.9K
RNAC icon
1523
Cartesian Therapeutics
RNAC
$262M
$49K ﹤0.01%
+620
New +$141K
ADMA icon
1524
ADMA Biologics
ADMA
$2.19B
$48K ﹤0.01%
+20,000
New +$99K
NEOS
1525
DELISTED
Neos Therapeutics, Inc
NEOS
$48K ﹤0.01%
29,300
+15,300
+109% +$42.9K
59 60
61
62 63

Similar funds

WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
PEAK6
PEAK6 Chicago, Illinois $42.6B AUM 66.24% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Newport Trust Company
Newport Trust Company Washington, District of Columbia $40.7B AUM 24.62% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

State of Wisconsin Investment Board's Q4 2018 Portfolio in Review

As of Q4 2018, State of Wisconsin Investment Board held 1,624 positions worth $30.7B, down 15% from $36.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

State of Wisconsin Investment Board's Q4 2018 filing shows 85 new, 603 increased, 480 reduced and 83 closed positions. Its largest new stake was Linde: 763,981 shares worth $120M. The largest sale was Twenty-First Century Fox, Inc. Class B, an estimated $140M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

  • State of Wisconsin Investment Board's largest Q4 2018 buy was Linde: 763,981 shares worth $120M.
  • State of Wisconsin Investment Board added most to DocuSign in Q4 2018, an estimated $126M increase.
  • State of Wisconsin Investment Board's biggest Q4 2018 reduction was Twenty-First Century Fox, Inc. Class B, cutting an estimated $140M.
  • State of Wisconsin Investment Board fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $103M.
  • State of Wisconsin Investment Board's ten largest holdings make up 16% of its $30.7B portfolio in Q4 2018.
  • State of Wisconsin Investment Board opened 85 new positions and closed 83 in Q4 2018.
  • State of Wisconsin Investment Board's portfolio value fell 15% quarter-over-quarter to $30.7B.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2018, filed 11 Feb 2019.